Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Exemestane in Neoadjuvant Breast Cancer
NCT00931450Phase 2Unknown
- Sponsor
- Institut Català d'Oncologia
- Start
- Mar 2009
- Primary completion
- Oct 2011
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sunitinib in breast cancer, sponsored by Institut Català d'Oncologia. Status: unknown.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00931450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931450.